References
  1. Celejewska-Wójcik N, Wójcik K, Ignacak-Popiel M, et al. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis. Allergy . 2020;75(4):831-840. doi:10.1111/all.14141
  2. Tyrak KE, Pajdzik K, Jakieła B, et al. Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease. Clin Exp Allergy . 2021;51(8):1046-1056. doi:10.1111/cea.13886
  3. Cahill KN, Cui J, Kothari P, et al. Unique effect of aspirin therapy on biomarkers in aspirin-exacerbated respiratory disease. A Prospective Trial. Am J Respir Crit Care Med . 2019;200(6):704-711. doi:10.1164/rccm.201809-1755OC
  4. Jerschow E, Edin ML, Pelletier T, et al. Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract . 2017;5(4):998-1007.e2. doi:10.1016/j.jaip.2016.11.021
  5. Dwyer DF. Eicosanoid relay: Epithelial and mast cell transmetabolism in AERD. J Allergy Clin Immunol . 2021;147(2):501-503. doi:10.1016/j.jaci.2020.12.627
  6. Haimerl P, Bernhardt U, Schindela S, et al. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. J Allergy Clin Immunol . 2021;147(2):587-599. doi:10.1016/j.jaci.2020.04.064
Authors : Lucyna Mastalerza, Radosław Kacorzyka, Bogdan Jakiełaa, Adam Ćmielb, Marek Sanaka
aII Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland
bDepartment of Applied Mathematics, AGH University of Science and Technology, Krakow, Poland
Address for correspondence: Prof. Marek Sanak
Department of Internal Medicine, Jagiellonian University Medical College,
ul. Skawińska 8, 31-066 Krakow, Poland
E-mail: marek.sanak@uj.edu.pl
Telephone number: 12 430 52 66
Word count (body): 599
Number of tables: 0
Number of figures: 2
Conflict of Interest: None declared.
Funding information: This work was supported by the National Science Centre, Poland (grant number UMO-2015/19/B/NZ5/00096; NCN).